Latest News and Press Releases

Biocomposites responds to NHS supply crisis by bringing forward launch of its SYNICEM™ bone cement products in the UKOver 500,000 SYNICEM™ bone cement packs are already used by surgeons globally every...

Pivya® (pivmecillinam) Tablets, 185mg Now Available by Prescription in the United States BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S....

STIMULAN® certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics STIMULAN® certified to resolve infection and reduce the need for secondary surgery STIMULAN® is the...

MicrobiotiX and KATH sign MoU to advance clinical bacteriophage therapies against AMR·MDR and expand treatment options for patients in Africa.

MicrobiotiX gains IND approval to initiate clinical trials for its pneumonia therapy designed to combat antibiotic-resistant superbugs.

MicrobiotiX raises KRW 20B Series B and wins grant to launch Korea’s first phage therapy trial, advancing fight against superbugs.

Austin, TX, USA, March 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Elastomeric Infusions Pumps Market Size, Trends and Insights By Product...

Austin, TX, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Empty Capsules Market Size, Trends and Insights By Type (Gelatin Capsules,...

Saint-Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive...

New York, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The global peri-implantitis treatment market size is projected to expand at ~8% CAGR between 2023 and 2035. The market is expected to garner a revenue of...